{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:31:18Z","timestamp":1789651878892,"version":"4.0.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Coxiella burnetii<\/jats:italic>, the etiologic agent of Q fever, replicates in an intracellular phagolysosome with pH between 4 and 5. The impact of this low pH environment on antimicrobial treatment is not well understood. An <jats:italic>in vitro<\/jats:italic> system for testing antibiotic susceptibility of <jats:italic>C. burnetii<\/jats:italic> in axenic media was set up to evaluate the impact of pH on <jats:italic>C. burnetii<\/jats:italic> growth and survival in the presence and absence of antimicrobial agents. The data show that <jats:italic>C. burnetii<\/jats:italic> does not grow in axenic media at pH 6.0 or higher, but the organisms remain viable. At pH of 4.75, 5.25, and 5.75 moxifloxacin, doxycycline, and rifampin are effective at preventing growth of <jats:italic>C. burnetii<\/jats:italic> in axenic media, with moxifloxacin and doxycycline being bacteriostatic and rifampin having bactericidal activity. The efficacy of doxycycline and moxifloxacin improved at higher pH, whereas rifampin activity was pH independent. Hydroxychloroquine is thought to inhibit growth of <jats:italic>C. burnetii in vivo<\/jats:italic> by raising the pH of typically acidic intracellular compartments. It had no direct bactericidal or bacteriostatic activity on <jats:italic>C. burnetii<\/jats:italic> in axenic media, suggesting that raising pH of acidic intracellular compartments is its primary mechanism of action <jats:italic>in vivo<\/jats:italic>. The data suggest that doxycycline and hydroxychloroquine are primarily independent bacteriostatic agents.<\/jats:p>","DOI":"10.1038\/s41598-019-54556-6","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:37:14Z","timestamp":1575286634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Effect of pH on Antibiotic Efficacy against Coxiella burnetii in Axenic Media"],"prefix":"10.1038","volume":"9","author":[{"given":"Cody B.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Evavold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-3579","authenticated-orcid":false,"given":"Gilbert J.","family":"Kersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"54556_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1462-5822.2007.00901.x","volume":"9","author":"DE Voth","year":"2007","unstructured":"Voth, D. E. & Heinzen, R. A. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cellular microbiology 9, 829\u2013840, https:\/\/doi.org\/10.1111\/j.1462-5822.2007.00901.x (2007).","journal-title":"Cellular microbiology"},{"key":"54556_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/15303660260613747","volume":"2","author":"JH McQuiston","year":"2002","unstructured":"McQuiston, J. H. & Childs, J. E. Q fever in humans and animals in the United States. Vector Borne & Zoonotic Diseases 2, 179\u2013191 (2002).","journal-title":"Vector Borne & Zoonotic Diseases"},{"key":"54556_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/br.25.3.285-293.1961","volume":"25","author":"WD Tigertt","year":"1961","unstructured":"Tigertt, W. D., Benenson, A. S. & Gochenour, W. S. Airborne Q fever. Bacteriological Reviews 25, 285\u2013293 (1961).","journal-title":"Bacteriological Reviews"},{"key":"54556_CR4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/jb.147.3.1063-1076.1981","volume":"147","author":"TF McCaul","year":"1981","unstructured":"McCaul, T. F. & Williams, J. C. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 147, 1063\u20131076 (1981).","journal-title":"J Bacteriol"},{"key":"54556_CR5","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1128\/JB.186.21.7344-7352.2004","volume":"186","author":"SA Coleman","year":"2004","unstructured":"Coleman, S. A., Fischer, E. R., Howe, D., Mead, D. J. & Heinzen, R. A. Temporal analysis of Coxiella burnetii morphological differentiation. Journal of Bacteriology 186, 7344\u20137352 (2004).","journal-title":"Journal of Bacteriology"},{"key":"54556_CR6","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1128\/AEM.03472-12","volume":"79","author":"GJ Kersh","year":"2013","unstructured":"Kersh, G. J. et al. Presence and Persistence of Coxiella burnetii in the Environments of Goat Farms Associated with a Q Fever Outbreak. Appl Environ Microbiol 79, 1697\u20131703, https:\/\/doi.org\/10.1128\/AEM.03472-12 (2013).","journal-title":"Appl Environ Microbiol"},{"key":"54556_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1128\/CMR.12.4.518","volume":"12","author":"M Maurin","year":"1999","unstructured":"Maurin, M. & Raoult, D. Q fever. Clinical Microbiology Reviews 12, 518\u2013553 (1999).","journal-title":"Clinical Microbiology Reviews"},{"key":"54556_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3201\/eid1804.111478","volume":"18","author":"LM Kampschreur","year":"2012","unstructured":"Kampschreur, L. M. et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis 18, 563\u2013570, https:\/\/doi.org\/10.3201\/eid1804.111478 (2012).","journal-title":"Emerg Infect Dis"},{"key":"54556_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.11.023","author":"SE van Roeden","year":"2018","unstructured":"van Roeden, S. E. et al. Chronic Q fever-related complications and mortality: data from a nationwide cohort. Clin Microbiol Infect. https:\/\/doi.org\/10.1016\/j.cmi.2018.11.023 (2018).","journal-title":"Clin Microbiol Infect"},{"key":"54556_CR10","first-page":"1","volume":"62","author":"A Anderson","year":"2013","unstructured":"Anderson, A. et al. Diagnosis and Management of Q Fever \u2014 United States, 2013: Recommendations from CDC and the Q Fever Working Group. MMWR. Morbidity and mortality weekly report 62, 1\u201323 (2013).","journal-title":"MMWR. Morbidity and mortality weekly report"},{"key":"54556_CR11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1586\/14787210.2013.840534","volume":"11","author":"GJ Kersh","year":"2013","unstructured":"Kersh, G. J. Antimicrobial therapies for Q fever. Expert Rev Anti Infect Ther 11, 1207\u20131214, https:\/\/doi.org\/10.1586\/14787210.2013.840534 (2013).","journal-title":"Expert Rev Anti Infect Ther"},{"key":"54556_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/archinte.159.2.167","volume":"159","author":"D Raoult","year":"1999","unstructured":"Raoult, D. et al. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 159, 167\u2013173 (1999).","journal-title":"Arch Intern Med"},{"key":"54556_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/infdis\/166.5.1097","volume":"166","author":"M Maurin","year":"1992","unstructured":"Maurin, M., Benoliel, A. M., Bongrand, P. & Raoult, D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. The Journal of infectious diseases 166, 1097\u20131102 (1992).","journal-title":"The Journal of infectious diseases"},{"key":"54556_CR14","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1128\/AAC.34.8.1512","volume":"34","author":"D Raoult","year":"1990","unstructured":"Raoult, D., Drancourt, M. & Vestris, G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrobial agents and chemotherapy 34, 1512\u20131514 (1990).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"54556_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S1473-3099(10)70135-3","volume":"10","author":"M Million","year":"2010","unstructured":"Million, M., Thuny, F., Richet, H. & Raoult, D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. The Lancet infectious diseases 10, 527\u2013535, https:\/\/doi.org\/10.1016\/S1473-3099(10)70135-3 (2010).","journal-title":"The Lancet infectious diseases"},{"key":"54556_CR16","unstructured":"IBM Micromedex, https:\/\/www.micromedexsolutions.com\/ (2019)."},{"key":"54556_CR17","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1128\/AEM.02826-10","volume":"77","author":"A Omsland","year":"2011","unstructured":"Omsland, A. et al. Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium. Appl Environ Microbiol 77, 3720\u20133725, https:\/\/doi.org\/10.1128\/AEM.02826-10 (2011).","journal-title":"Appl Environ Microbiol"},{"key":"54556_CR18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.ijantimicag.2017.08.006","volume":"51","author":"KA Clay","year":"2018","unstructured":"Clay, K. A., Hartley, M. G., Russell, P. & Norville, I. H. Use of axenic media to determine antibiotic efficacy against coxiella burnetii. International journal of antimicrobial agents 51, 806\u2013808, https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.006 (2018).","journal-title":"International journal of antimicrobial agents"},{"key":"54556_CR19","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1073\/pnas.0812074106","volume":"106","author":"A Omsland","year":"2009","unstructured":"Omsland, A. et al. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proceedings of the National Academy of Sciences of the United States of America 106, 4430\u20134434 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"54556_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mimet.2013.11.010","volume":"96","author":"KM Sandoz","year":"2014","unstructured":"Sandoz, K. M., Sturdevant, D. E., Hansen, B. & Heinzen, R. A. Developmental transitions of Coxiella burnetii grown in axenic media. J Microbiol Methods 96, 104\u2013110, https:\/\/doi.org\/10.1016\/j.mimet.2013.11.010 (2014).","journal-title":"J Microbiol Methods"},{"key":"54556_CR21","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1073\/pnas.75.7.3327","volume":"75","author":"S Ohkuma","year":"1978","unstructured":"Ohkuma, S. & Poole, B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 75, 3327\u20133331, https:\/\/doi.org\/10.1073\/pnas.75.7.3327 (1978).","journal-title":"Proc Natl Acad Sci USA"},{"key":"54556_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.idc.2009.06.008","volume":"23","author":"ME Levison","year":"2009","unstructured":"Levison, M. E. & Levison, J. H. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin North Am 23, 791\u2013815, vii, https:\/\/doi.org\/10.1016\/j.idc.2009.06.008 (2009).","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"54556_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I. Chopra","year":"2001","unstructured":"Chopra, I. & Roberts, M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65, 232\u2013260; second page, table of contents, https:\/\/doi.org\/10.1128\/MMBR.65.2.232-260.2001 (2001).","journal-title":"Microbiology and Molecular Biology Reviews"},{"key":"54556_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/CMR.00034-09","volume":"23","author":"GN Forrest","year":"2010","unstructured":"Forrest, G. N. & Tamura, K. Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev 23, 14\u201334, https:\/\/doi.org\/10.1128\/CMR.00034-09 (2010).","journal-title":"Clin Microbiol Rev"},{"key":"54556_CR25","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1128\/AAC.37.7.1393","volume":"37","author":"H Nikaido","year":"1993","unstructured":"Nikaido, H. & Thanassi, D. G. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrobial agents and chemotherapy 37, 1393\u20131399 (1993).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"54556_CR26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/jb.154.2.591-597.1983","volume":"154","author":"T Hackstadt","year":"1983","unstructured":"Hackstadt, T. Estimation of the cytoplasmic pH of Coxiella burnetii and effect of substrate oxidation on proton motive force. J Bacteriol 154, 591\u2013597 (1983).","journal-title":"J Bacteriol"},{"key":"54556_CR27","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1128\/AAC.02463-14","volume":"58","author":"PS Ocampo","year":"2014","unstructured":"Ocampo, P. S. et al. Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrobial agents and chemotherapy 58, 4573\u20134582, https:\/\/doi.org\/10.1128\/AAC.02463-14 (2014).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"54556_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jvs.2005.03.022","volume":"42","author":"C Sessa","year":"2005","unstructured":"Sessa, C. et al. Abdominal aortic aneurysm and Coxiella burnetii infection: report of three cases and review of the literature. J Vasc Surg 42, 153\u2013158, https:\/\/doi.org\/10.1016\/j.jvs.2005.03.022 (2005).","journal-title":"J Vasc Surg"},{"key":"54556_CR29","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1128\/IAI.70.12.6726-2733.2002","volume":"70","author":"TA Hoover","year":"2002","unstructured":"Hoover, T. A., Culp, D. W., Vodkin, M. H., Williams, J. C. & Thompson, H. A. Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain. Infection and immunity 70, 6726\u20136733 (2002).","journal-title":"Infection and immunity"},{"key":"54556_CR30","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1128\/JCM.00758-10","volume":"48","author":"GJ Kersh","year":"2010","unstructured":"Kersh, G. J. et al. Coxiella burnetii infection of a Steller sea lion (Eumetopias jubatus) found in Washington State. J Clin Microbiol 48, 3428\u20133431, https:\/\/doi.org\/10.1128\/JCM.00758-10 (2010).","journal-title":"J Clin Microbiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54556-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54556-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54556-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:52:55Z","timestamp":1671295975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54556-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54556"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54556-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18132"}}